Sign in

CIK 0000949858 · Non-accelerated filer<br>Smaller reporting company

ACHIEVE LIFE SCIENCES, INC.

Sign in to watch
Tickers
ACHV QUIT
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
954343413
Phone
425-686-1500
Business address
22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
Former names
ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC

Securities

  • ACHV Common stock Nasdaq
  • QUIT Common Shares Nasdaq
  1. 10-K Report Annual Report
  2. 8-K Event Results of operations
  3. 8-K Event Delisting notice
  4. 8-K Event Results of operations · Exit or restructuring costs
  5. 8-K Event Other events
  6. 8-K Event Other events
  7. 8-K Event Other events
  8. 8-K Event Results of operations
  9. 8-K Event Other events
  10. 8-K Event Results of operations
  11. 8-K Event Other events
  12. 8-K Event Bylaws or fiscal year change · Shareholder vote results
  13. 8-K Event Results of operations
  14. 8-K Event Material agreement · Acquisition or sale completed · Other events
  15. 8-K Event Material agreement · Agreement ended · Regulation FD disclosure
  16. DEF 14A Proxy Proxy Statement
  17. 10-K Report Annual Report
  18. 8-K Event Results of operations
  19. 8-K Event Material agreement · Agreement ended · New debt or obligation
  20. 8-K Event Material agreement · Regulation FD disclosure

Page 8 of 17 · 336 filings